← Product Code [JCO](/submissions/HE/subpart-i%E2%80%94hematology-reagents/JCO) · K932787

# BATROXOBIN REAGENT (K932787)

_Behring Diagnostics, Inc. · JCO · Nov 29, 1993 · Hematology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/HE/subpart-i%E2%80%94hematology-reagents/JCO/K932787

## Device Facts

- **Applicant:** Behring Diagnostics, Inc.
- **Product Code:** [JCO](/submissions/HE/subpart-i%E2%80%94hematology-reagents/JCO.md)
- **Decision Date:** Nov 29, 1993
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 864.8100
- **Device Class:** Class 2
- **Review Panel:** Hematology

## Regulatory Identification

A Bothrops atrox reagent is a device made from snake venom and used to determine blood fibrinogen levels to aid in the evaluation of disseminated intravascular coagulation (nonlocalized clotting in the blood vessels) in patients receiving heparin therapy (the administration of the anticoagulant heparin in the treatment of thrombosis) or as an aid in the classification of dysfibrinogenemia (presence in the plasma of functionally defective fibrinogen).

---

**Source:** [https://fda.innolitics.com/submissions/HE/subpart-i%E2%80%94hematology-reagents/JCO/K932787](https://fda.innolitics.com/submissions/HE/subpart-i%E2%80%94hematology-reagents/JCO/K932787)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com